{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T16:14:54Z","timestamp":1789748094448,"version":"4.0.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2015,3,27]],"date-time":"2015-03-27T00:00:00Z","timestamp":1427414400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Nucl Med"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1007\/s12149-015-0963-9","type":"journal-article","created":{"date-parts":[[2015,3,26]],"date-time":"2015-03-26T09:43:36Z","timestamp":1427363016000},"page":"431-441","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Impact of FDG-PET findings on decisions regarding patient management strategies: a multicenter trial in patients with lung cancer and other types of cancer"],"prefix":"10.1007","volume":"29","author":[{"given":"Kazuo","family":"Kubota","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinsuke","family":"Matsuno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuo","family":"Morioka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuji","family":"Adachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuru","family":"Koizumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hikaru","family":"Seto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motohisa","family":"Kojo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Nishioka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michihiko","family":"Nishimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,3,27]]},"reference":[{"key":"963_CR1","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1177\/0272989X9101100203","volume":"11","author":"DG Fryback","year":"1991","unstructured":"Fryback DG, Thornbury JR. The efficacy of diagnostic imaging. Med Decis Making. 1991;11:88\u201394.","journal-title":"Med Decis Making"},{"key":"963_CR2","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/S1076-6332(00)80524-3","volume":"7","author":"F Houn","year":"2000","unstructured":"Houn F, Bright RA, Bushar HF, Croft BY, Finder CA, Gohagan JK, et al. Study design in the evaluation of breast cancer imaging technologies. Acad Radiol. 2000;7:684\u201392.","journal-title":"Acad Radiol"},{"key":"963_CR3","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1001\/jama.285.7.914","volume":"285","author":"MK Gould","year":"2001","unstructured":"Gould MK, Maclean CC, Kuschner WG, Rydzak CE, Owens DK. Accuracy of positron emission tomography for diagnosis of pulmonary nodules and mass lesions. A meta-analysis. JAMA. 2001;285:914\u201324.","journal-title":"JAMA"},{"key":"963_CR4","doi-asserted-by":"crossref","first-page":"879","DOI":"10.7326\/0003-4819-139-11-200311180-00013","volume":"139","author":"MK Gould","year":"2003","unstructured":"Gould MK, Kuschner WG, Rydzak CE, Maclean CC, Demas AN, Shigemitsu H, et al. Test performance of positron emission tomography and computed tomography for mediastinal staging in patients with non-small-cell lung cancer. A meta-analysis. Ann Intern Med. 2003;139:879\u201392.","journal-title":"Ann Intern Med"},{"key":"963_CR5","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1016\/j.jtcvs.2003.07.030","volume":"126","author":"CE Reed","year":"2003","unstructured":"Reed CE, Harpole DH, Posther KE, Woolson SL, Downey RJ, Meyers BF, et al. Results of the American College of Surgeons Oncology Group Z0050 trial: the utility of positron emission tomography in staging potentially operable non-small cell lung cancer. J Thorac Cardiovasc Surg. 2003;126:1943\u201351.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"963_CR6","first-page":"1301","volume":"44","author":"RC Delgado-Bolton","year":"2003","unstructured":"Delgado-Bolton RC, Fern\u00e1ndez-P\u00e9rez C, Gonz\u00e1lez-Mat\u00e9 A, Carreras JL. Meta-analysis of the performance of 18F-FDG PET in primary tumor detection in unknown primary tumors. J Nucl Med. 2003;44:1301\u201314.","journal-title":"J Nucl Med"},{"key":"963_CR7","first-page":"153","volume":"44","author":"J Schwimmer","year":"2000","unstructured":"Schwimmer J, Essner R, Patel A, Jahan SA, Shepherd JE, Park K, et al. A review of the literature for whole-body FDG PET in the management of patients with melanoma. Q J Nucl Med. 2000;44:153\u201367.","journal-title":"Q J Nucl Med"},{"key":"963_CR8","first-page":"1125","volume":"41","author":"PE Valk","year":"2000","unstructured":"Valk PE. Randomized controlled trials are not appropriate for imaging technology evaluation. J Nucl Med. 2000;41:1125\u20136.","journal-title":"J Nucl Med"},{"key":"963_CR9","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1200\/JCO.2001.19.1.111","volume":"19","author":"V Kalff","year":"2001","unstructured":"Kalff V, Hicks RJ, MacManus MP, Binns DS, McKenzie AF, Ware RE, et al. Clinical impact of 18F fluorodeoxyglucose positron emission tomography in patients with non-small-cell lung cancer: a prospective study. J Clin Oncol. 2001;19:111\u20138.","journal-title":"J Clin Oncol"},{"key":"963_CR10","doi-asserted-by":"crossref","first-page":"3248","DOI":"10.1200\/JCO.2004.11.089","volume":"22","author":"JD Bradley","year":"2004","unstructured":"Bradley JD, Dehdashti F, Mintun MA, Govindan R, Trinkaus K, Siegel BA. Positron emission tomography in limited-stage small-cell lung cancer: a prospective study. J Clin Oncol. 2004;22:3248\u201354.","journal-title":"J Clin Oncol"},{"key":"963_CR11","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ijrobp.2003.10.044","volume":"59","author":"J Bradley","year":"2004","unstructured":"Bradley J, Thorstad WL, Mutic S, Miller TR, Dehdashti F, Siegel BA, et al. Impact of FDG-PET on radiation therapy volume delineation in non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2004;59:78\u201386.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"963_CR12","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.lungcan.2003.11.007","volume":"44","author":"AFT Verhagen","year":"2004","unstructured":"Verhagen AFT, Bootsma GP, Tjan-Heijnen VCG, van der Wilt GJ, Cox AL, Brouwer MHJ, et al. FDG-PET in staging lung cancer: how does it change the algorithm? Lung Cancer. 2004;44:175\u201381.","journal-title":"Lung Cancer"},{"key":"963_CR13","first-page":"1911","volume":"44","author":"EM Kamel","year":"2003","unstructured":"Kamel EM, Zwahlen D, Wyss MT, Stumpe KD, von Schulthess GK, SteinertHC. Whole-body 18F-FDG PET improves the management of patients with small cell lung cancer. J Nucl Med. 2003;44:1911\u20137.","journal-title":"J Nucl Med"},{"key":"963_CR14","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/S0003-4975(03)00888-9","volume":"76","author":"RJ Cerfolio","year":"2003","unstructured":"Cerfolio RJ, Ojha B, Bryant AS, Bass CS, Bartalucci AA, Mountz JM. The role of FDG-PET scan in staging patients with nonsmall cell carcinoma. Ann Thorac Surg. 2003;76:861\u20136.","journal-title":"Ann Thorac Surg"},{"key":"963_CR15","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1136\/thorax.58.1.47","volume":"58","author":"GJ Herder","year":"2003","unstructured":"Herder GJ, van Tinteren H, Comans EF, Hoekstra OS, Teule GJ, Postmus PE, et al. Prospective use of serial questionnaires to evaluate the therapeutic efficacy of 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET) in suspected lung cancer. Thorax. 2003;58:47\u201351.","journal-title":"Thorax"},{"key":"963_CR16","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1067\/mtc.2002.123130","volume":"124","author":"H Vesselle","year":"2002","unstructured":"Vesselle H, Pugsley JM, Valli\u00e8res E, Wood DE. The impact of fluorodeoxyglucose F 18 positron-emission tomography on the surgical staging of non-small cell lung cancer. J Thorac Cardiovasc Surg. 2002;124:511\u20139.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"963_CR17","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1007\/s00259-002-0801-x","volume":"29","author":"SM Eschmann","year":"2002","unstructured":"Eschmann SM, Friedel G, Paulsen F, Budach W, Harer-Mouline C, Dohmen BM, et al. FDG PET for staging of advanced non-small cell lung cancer prior to neoadjuvant radio-chemotherapy. Eur J Nucl Med. 2002;29:804\u20138.","journal-title":"Eur J Nucl Med"},{"key":"963_CR18","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0360-3016(01)01824-7","volume":"52","author":"K Mah","year":"2002","unstructured":"Mah K, Caldwell CB, Ung YC, Danjoux CE, Balogh JM, Ganguli SN, et al. The impact of 18FDG-PET on target and critical organs in CT-based treatment planning of patients with poorly defined non-small-cell lung carcinoma: a prospective study. Int J Radiat Oncol Biol Phys. 2002;52:339\u201350.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"963_CR19","first-page":"1605","volume":"42","author":"RJ Hicks","year":"2001","unstructured":"Hicks RJ, Kalff V, MacManus MP, Ware RE, McKenzie AF, Matthews JP, et al. The utility of 18F-FDG PET for suspected recurrent non-small cell lung cancer after potentially curative therapy: impact on management and prognostic stratification. J Nucl Med. 2001;42:1605\u201313.","journal-title":"J Nucl Med"},{"key":"963_CR20","first-page":"1596","volume":"42","author":"RJ Hicks","year":"2001","unstructured":"Hicks RJ, Kalff V, MacManus MP, Ware RE, Hogg A, McKenzie AF, et al. 18F-FDG PET provides high-impact and powerful prognostic stratification in staging newly diagnosed non-small cell lung cancer. J Nucl Med. 2001;42:1596\u2013604.","journal-title":"J Nucl Med"},{"key":"963_CR21","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1002\/1097-0142(20010815)92:4<886::AID-CNCR1397>3.0.CO;2-V","volume":"92","author":"MP MacManus","year":"2001","unstructured":"MacManus MP, Hicks RJ, Ball DL, Kalff V, Matthews JP, Salminen E, et al. F-18 fluorodeoxyglucose positron emission tomography staging in radical radiotherapy candidates with nonsmall cell lung carcinoma: powerful correlation with survival and high impact on treatment. Cancer. 2001;92:886\u201395.","journal-title":"Cancer"},{"key":"963_CR22","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/00000421-200002000-00014","volume":"23","author":"E Weng","year":"2000","unstructured":"Weng E, Tran L, Rege S, Safa A, Sadeghi A, Juillard G, et al. Accuracy and clinical impact of mediastinal lymph node staging with FDG-PET imaging in potentially resectable lung cancer. Am J Clin Oncol. 2000;23:47\u201352.","journal-title":"Am J Clin Oncol"},{"key":"963_CR23","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/S0003-4975(98)01257-0","volume":"67","author":"CAB Saunders","year":"1999","unstructured":"Saunders CAB, Dussek JE, O\u2019Doherty MJ, Maisey MN. Evaluation of fluorine-18-fluorodeoxyglucose whole body positron emission tomography imaging in the staging of lung cancer. Ann Thorac Surg. 1999;67:790\u20137.","journal-title":"Ann Thorac Surg"},{"key":"963_CR24","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0169-5002(97)00086-X","volume":"19","author":"JD Kiffer","year":"1998","unstructured":"Kiffer JD, Berlangieri SU, Scott AM, Quong G, Feigen M, Schumer W, et al. The contribution of 18F-fluoro-2-deoxy-glucose positron emission tomographic imaging to radiotherapy planning in lung cancer. Lung Cancer. 1998;19:167\u201377.","journal-title":"Lung Cancer"},{"key":"963_CR25","doi-asserted-by":"crossref","first-page":"479","DOI":"10.2214\/ajr.183.2.1830479","volume":"183","author":"WB Eubank","year":"2004","unstructured":"Eubank WB, Mankoff D, Bhattacharya M, Gralow J, Linden H, Ellis G, et al. Impact of FDG PET on defining the extent of disease and on the treatment of patients with recurrent or metastatic breast cancer. AJR Am J Roentgenol. 2004;183:479\u201386.","journal-title":"AJR Am J Roentgenol"},{"key":"963_CR26","first-page":"492","volume":"43","author":"V Kalff","year":"2002","unstructured":"Kalff V, Hicks RJ, Ware RE, Hogg A, Binns D, McKenzie AF. The clinical impact of 18F-FDG PET in patients with suspected or confirmed recurrence of colorectal cancer: a prospective study. J Nucl Med. 2002;43:492\u20139.","journal-title":"J Nucl Med"},{"key":"963_CR27","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1097\/00005537-200009000-00016","volume":"110","author":"M Lonneux","year":"2000","unstructured":"Lonneux M, Lawson G, Ide C, Bausart R, Remacle M, Pauwels S. Positron emission tomography with fluorodeoxyglucose for suspected head and neck tumor recurrence in the symptomatic patient. Laryngoscope. 2000;110:1493\u20137.","journal-title":"Laryngoscope"},{"key":"963_CR28","unstructured":"Ministry of Health and Welfare. Ministerial Ordinance. No. 28 dated March 27 1997 (in Japanese)."},{"key":"963_CR29","unstructured":"Ministry of Health and Welfare. Ministerial Ordinance. No. 171 dated December 20 2004 (in Japanese)."},{"key":"963_CR30","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1200\/JCO.2007.14.5631","volume":"26","author":"BE Hillner","year":"2008","unstructured":"Hillner BE, Siegel BA, Liu D, Shields AF, Gareen IF, Hanna L, et al. Impact of positron emission tomography\/computed tomography and positron emission tomography (PET) alone on expected management of patients with cancer: initial results from the National Oncologic PET Registry. J Clin Oncol. 2008;26:2155\u201361.","journal-title":"J Clin Oncol"}],"container-title":["Annals of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-015-0963-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12149-015-0963-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-015-0963-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,22]],"date-time":"2019-08-22T08:31:58Z","timestamp":1566462718000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12149-015-0963-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3,27]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["963"],"URL":"https:\/\/doi.org\/10.1007\/s12149-015-0963-9","relation":{},"ISSN":["0914-7187","1864-6433"],"issn-type":[{"value":"0914-7187","type":"print"},{"value":"1864-6433","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,27]]}}}